Jul 9, 2026 05:18PM
Jun 30, 2026 08:04AM
May 28, 2026 10:23AM
May 8, 2026 10:05AM
May 7, 2026 12:40PM
May 7, 2026 08:02AM
May 7, 2026 05:59AM Catalyst Pharmaceuticals settles FIRDAPSE patent case with Hetero Labs
Apr 27, 2026 04:15PM
Apr 27, 2026 03:36PM
Apr 27, 2026 12:06PM
Apr 14, 2026 02:12PM
Mar 6, 2026 08:04AM
Feb 27, 2026 06:00AM
Feb 25, 2026 04:35PM Catalyst Pharmaceuticals (CPRX) Tops Q4 EPS by 37c, Offers Guidance
Nov 5, 2025 04:47PM
Aug 25, 2025 08:03AM
Aug 6, 2025 04:54PM
Jun 2, 2025 08:08AM
May 7, 2025 04:26PM
Apr 8, 2025 08:07AM
Apr 8, 2025 08:06AM Catalyst Pharmaceuticals (CPRX) New Drug Submission for AGAMREE Accepted for Priority Review by Health Canada for the Treatment of Duchenne Muscular Dystrophy
Mar 13, 2025 06:58AM
Feb 28, 2025 07:08AM
Feb 26, 2025 04:24PM
Feb 4, 2025 05:07AM
Jan 21, 2025 02:21PM
Jan 21, 2025 08:20AM
Jan 8, 2025 03:06PM Oppenheimer on Catalyst Pharmaceutical (CPRX): 'We believe that uncertainty around this topic had kept many on the sidelines and that today's update will facilitate investor interest'
Jan 8, 2025 03:05PM
Jan 8, 2025 03:04PM
Jan 8, 2025 12:31PM
Jan 8, 2025 12:25PM
Dec 17, 2024 06:17AM
Nov 6, 2024 04:23PM
Sep 24, 2024 06:20AM Catalyst Pharmaceuticals (CPRX) Announces Sub-Licensee DyDo Pharma Received Approval to Commercialize FIRDAPSE in Japan
Aug 12, 2024 06:28AM
Aug 9, 2024 04:56AM
Aug 7, 2024 04:24PM
Aug 7, 2024 10:00AM
Jul 24, 2024 08:08AM
Apr 2, 2024 10:00AM

427,076 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All